An Early Phase 1 interventional study of Floatation-REST and Documentary in Posttraumatic Stress Symptoms, Burnout and Burnout, Healthcare Workers, sponsored by Laureate Institute for Brain Research, Inc.. Recruiting at 1 site in United States. Open to participants aged 18 Years to 64 Years. Per ClinicalTrials.gov, last updated 2026-07-17.
Sponsored by Laureate Institute for Brain Research, Inc. · Early Phase 1, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 149 studies in Burnout, Psychological with a site in United States — 29 open to participants now, 41 under way, none of them phase 3. Burnout, Psychological · United States.
Among the 149 studies in Burnout, Psychological with a site in United States, this one is the 120th largest by planned enrollment of the 134 interventional ones that give a count, is one of 16 that started in 2026, is one of 3 in phase 1, reaches primary completion later than 14 of the 40 other live ones, and was the 140th registered.
468 studies on the registry are indexed under Burnout, Psychological; 121 are open to participants now.
Browse Burnout, Psychological studies →29 of the 149 studies in Burnout, Psychological with a site in United States are open now. Recruiting first, the newest first:
University of Texas at Austin · Sites in United States
Ages 18–100
Brigham and Women's Hospital · Sites in United States
Ages 18+
Efforia, Inc · Sites in United States
Ages 18+ · Healthy volunteers
AdventHealth · Sites in United States
Healthy volunteers
Mayo Clinic · Sites in United States
Ages 18–85 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 65 Burnout, Psychological studies recruiting now, 43 (66%) set no upper age limit and 16 (25%) stop at 75 or younger; 14 take children under 18; 33 take healthy volunteers.
This study: 18 Years to 64 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
149 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 3 · Phase 4 1
First in 2008; this study’s year is marked. 16 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 15 is below the median of 80 across 344 interventional studies indexed under Burnout, Psychological.
Median enrollment 80 across the 134 interventional studies, 50 across the 15 observational. Of the 101 that completed or were terminated, 16 (16%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 149 have an industry lead sponsor. The 10 most frequent:
Laureate Institute for Brain Research, Inc. is the lead sponsor of 54 studies on the registry; 11 are open to participants now.
Laureate Institute for Brain Research, Inc. has 1 study filed under Burnout, Psychological — fewer than ten, so there is no comparison to draw.
16 of the studies in Burnout, Psychological with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07742761Washington University School of MedicineEmergency Medicine Practitioners Overall Well-being Enhancement With Ambient AI Scribes | 2026-12 |
| NCT07773168Brigham and Women's HospitalBurnout and Safety Assessment in Home Hospital Versus Brick-and-Mortar Hospital | 2026-12 |
| NCT07710417Laureate Institute for Brain Research, Inc.FLOAT for Healthcare PTSS | 2026-12 |
| NCT05942469Northwestern UniversityFostering Optimal Regulation of Emotion for Prevention of Secondary Trauma (FOREST) | 2026-12-31 |
| NCT07639827Massachusetts General HospitalA Study of a Mental Fitness Intervention for Anesthesiology Resident Wellbeing and Self-Compassion | 2027-01 |
Add all 16 to your calendar (.ics) → With an account.
Among the 149 studies in Burnout, Psychological with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This early-stage pilot trial aims to examine the feasibility, tolerability, and safety of Floatation-REST, or Reduced Environmental Stimulation Therapy via floatation in frontline healthcare workers, first responders, and emergency medical personnel who experience post-traumatic stress symptoms.
Frontline healthcare workers, first responders, and emergency medical personnel are repeatedly exposed to occupational stressors and potentially traumatic events, placing them at elevated risk for post-traumatic stress symptoms (PTSS), burnout, anxiety, and related impairments. Current stress-reduction approaches for healthcare workers often have limited evidence for efficacy or may be difficult to implement in high-demand emergency and healthcare settings. Therefore, rapid, low-burden interventions that are feasible, tolerable, and safe for this population are needed.
Floatation-REST, or Reduced Environmental Stimulation Therapy, is a non-pharmacological intervention that reduces sensory input to the nervous system through the act of floating supine in a pool of warm water saturated with Epsom salt. The float environment is designed to reduce visual, auditory, thermal, tactile, vestibular, and proprioceptive stimulation. Prior studies suggest that Floatation-REST may acutely reduce stress and anxiety-related symptoms, but it has not yet been systematically evaluated in frontline healthcare workers with elevated PTSS.
This single-site, double-arm pilot study will examine the feasibility, tolerability, and safety of two 60-minute sessions of Floatation-REST compared with a documentary-viewing condition in adults ages 18 to 64 with work-related post-traumatic stress symptoms. Up to 30 participants will be recruited, with the goal of retaining 15 completers randomized on a 2:1 basis to Floatation-REST versus comparator condition. Participants will complete two in-person study visits at the Laureate Institute for Brain Research, including self-report questionnaires, blood and saliva collection, functional magnetic resonance imaging scans, and either Floatation-REST or documentary viewing. Follow-up surveys will be completed virtually up to one week after final intervention session.
The primary aim is to evaluate the safety and tolerability of Floatation-REST in this population. Secondary aims will explore whether Floatation-REST is associated with acute changes in PTSS, perceived stress, anxiety, burnout, mood, mindfulness, and moral injury-related distress. Exploratory aims will examine whether changes in brain network connectivity, salivary cortisol, and blood-based proteomic markers may help explain symptom change. Results from this early-stage study will help determine whether Floatation-REST should be further studied as a potential intervention for post-traumatic stress symptoms in frontline healthcare and emergency personnel.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Work-related post-traumatic stress dysfunction as measured by either of the following inclusion pathways:
(A) PTSS Pathway: PCL-5 greater than or equal to 20, OR meets criteria for full or partial PTSD on the MINI International Neuropsychiatric Interview 7 () (Criteria A + at least 2 B-E Criteria) OR (B) Functionally Anchored Pathway: evidence of work-related trauma exposure on the MINI International Neuropsychiatric Interview 7 (DSM-V) (Criterion A) or Life Events Checklist-5, and at least one of the following: Moral Injury and Distress Scale greater than or equal to 27, Sheehan Disability Scale greater than or equal to 5 on at least 1 of the 3 subscales, high or very high level of perceived stress (measured by PhenX Perceived Stress Scale greater than or equal to 16).
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will float supine in a shallow pool for two one-hour sessions approximately seven days apart.
Behavioral: Floatation-REST
Participants will watch two one-hour documentaries in a relaxing environment approximately seven days apart.
Behavioral: Documentary
Participants float supine in a shallow pool of water saturated with Epsom salt. The environment is designed to minimize external stimulation via multiple channels including sound, light, and temperature.
Participants will sit in a quiet room and watch a documentary.
Adverse effects
Safety will be assessed using adverse events reported directly to study staff and adverse effects reported on the Floatation-REST effects checklist after each Floatation-REST or comparator session. As a proxy of safety, adverse effects will be calculated for each participant as the number of instances during the study in which the participant reports an increase above mild for any negatively experienced effect on the checklist.
Time frame: From baseline to post-intervention seven day follow-up
Dropout Rate
As a proxy for tolerability, dropout rate for each arm = (# of subjects who are withdrawn from the study)/(# participants in specific arm).
Time frame: Baseline through seven day post-intervention follow up
Burnout Effects of Floatation-REST
Burnout measured using the MBI-HSS questionnaire after each experimental session and at follow-up time points
Time frame: Baseline through seven day post-intervention follow up
Perceived Stress Effects of Floatation-REST
Perceived stress measured using the Perceived Stress Scale after each experimental session and at follow-up time points
Time frame: Baseline through seven day post-intervention follow up
Moral Injury Effects of Floatation-REST
Moral injury measured using the Moral Injury and Distress Scale after each experimental session and at follow-up time points
Time frame: Baseline through seven day post-intervention follow up
Depressive Symptomatology Effects of Floatation-REST
Depressive symptoms measured using the Quick Inventory of Depressive Symptomatology (QIDS-SR) after each experimental session and at follow-up time points
Time frame: Baseline through seven day post-intervention follow up
Started Jun 2026 (actual). Primary completion is estimated for Dec 2026, 6 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Laureate Institute for Brain Research, Inc.